Wisconsin Hospitals to Offer Celera's Cardiovascular Genetic Test | GenomeWeb

NEW YORK (GenomeWeb news) – Aurora Health Care of Milwaukee, Wis., will work with Celera to offer genetic cardiovascular tests under a new collaboration, Celera said yesterday.

Celera said that the agreement makes Aurora "the first health care provider in Wisconsin and one of the first in the nation" to offer the company's test for a variant in the KIF6 gene that has been shown to indicate increased risk for heart disease.

The company said that untreated carriers of the KIF6 gene variant have a 50 percent to 55 percent greater risk of heart attacks than non-carriers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.